EP Patent

EP3156406A1 — Crystalline forms of ribociclib free base

Assigned to Ratiopharm GmbH · Expires 2017-04-19 · 9y expired

What this patent protects

The present invention relates to crystalline ribociclib free base, methods of its preparation and a pharmaceutical composition comprising the same.

USPTO Abstract

The present invention relates to crystalline ribociclib free base, methods of its preparation and a pharmaceutical composition comprising the same.

Drugs covered by this patent

ribociclib-succinate (RIBOCICLIB SUCCINATE)

Patent Metadata

Patent number: EP3156406A1
Jurisdiction: EP
Classification: —
Expires: 2017-04-19
Drug substance claim: No
Drug product claim: No
Assignee: Ratiopharm GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.